Screener
Kymera Therapeutics KYMR Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Kymera Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: Kymera Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:15 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333849
FAQ
- What is Kymera Therapeutics's book value per share?
- Kymera Therapeutics (KYMR) reported book value per share of $15.37 in Q2 2026.
- How has Kymera Therapeutics's book value per share changed year-over-year?
- Kymera Therapeutics's book value per share increased by 27.3% year-over-year, from $12.08 to $15.37.
- What is the long-term trend for Kymera Therapeutics's book value per share?
- Over 5 years (2020 to 2025), Kymera Therapeutics's book value per share has grown at a 2.7% compound annual growth rate (CAGR), from $16.36 to $18.70.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Kymera Therapeutics's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude